The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 845 | 16,485 | SH | DFND | 1 | 16,485 | 0 | 0 | |
| CALPINE CORP | COM NEW | 131347304 | 8,283 | 749,553 | SH | DFND | 1 | 749,553 | 0 | 0 | |
| CALPINE CORP | COM NEW | 131347304 | 2,128 | 192,550 | SH | DFND | 192,550 | 0 | 0 | ||
| DAVITA INC | COM | 23918K108 | 3,353 | 49,335 | SH | DFND | 1 | 49,335 | 0 | 0 | |
| DAVITA INC | COM | 23918K108 | 963 | 14,171 | SH | DFND | 14,171 | 0 | 0 | ||
| MEDICINES CO | COM | 584688105 | 1,683 | 34,423 | SH | DFND | 1 | 34,423 | 0 | 0 | |
| RETROPHIN INC | COM | 761299106 | 1,553 | 84,111 | SH | DFND | 1 | 84,111 | 0 | 0 | |
| SERITAGE GROWTH PPTYS | CL A | 81752R100 | 4,028 | 93,353 | SH | DFND | 1 | 93,353 | 0 | 0 | |
| SERITAGE GROWTH PPTYS | CL A | 81752R100 | 989 | 22,928 | SH | DFND | 22,928 | 0 | 0 | ||
| TRIPADVISOR INC | COM | 896945201 | 8,082 | 187,262 | SH | DFND | 1 | 187,262 | 0 | 0 | |
| TRIPADVISOR INC | COM | 896945201 | 2,329 | 53,967 | SH | DFND | 53,967 | 0 | 0 | ||